Gerald Rigdon

Fellow, Software Engineering Boston Scientific Corporation

I have over 35 years of experience in safety critical software driven real-time embedded systems spanning multiple diverse industries, Process Control Instrumentation, Burner Controls, Dynamically Stabilized Balancing Machines, and Medical Devices. I spent 11 years leading the software development in a small private industrial instrumentation company, 2 years owning burner control projects, 6 years wearing numerous hats in a renowned startup company, and presently 18 years in a senior staff technical leadership position for a large publicly owned medical device corporation. Hands-on in all stages of the software development process in dynamic safety/security critical environments with breakthrough technologies.

Seminars

Wednesday 22nd July 2026
Panel: Proving AI Safety Through Robust Validation Beyond Performance Metrics
12:10 pm
  • Understand why AUC, sensitivity, and specificity are insufficient to demonstrate clinical safety
  • The “no gold standard” problem: disagreement among clinicians as a validation challenge
  • Identifying bias, edge cases, and underrepresented populations in training/testing data
  • Integrating AI validation with risk management, V&V, and regulatory evidence expectations
Wednesday 22nd July 2026
Fishbowl Debate: Assistive vs. Autonomous AI: Where Should Humans Stay in the Loop?
4:30 pm

This dynamic fishbowl debate brings engineers, clinicians, and regulatory leaders into a rotating inner‑circle conversation, creating a rare, real‑time exchange between those designing AI systems, those deploying them, and those overseeing their safety. With audience members stepping into the discussion throughout, the session becomes a living model of the very human‑machine interaction it examines.

  • Discuss how assistive, decision‑support, and autonomous AI shift risk, validation, and oversight, enabling attendees to match autonomy levels to the appropriate regulatory and safety strategy
  • Examine where AI improves consistency and where it introduces over‑reliance or hidden errors, giving participants clearer judgment on when human review adds safety value
  • Explore how claims, labelling, and clinical context constrain autonomy, helping attendees align design decisions with regulatory positioning
  • Break down models for “human in the loop,” “on the loop,” and supervisory control guiding teams to design workflows, interfaces, and monitoring that meet regulator and clinician expectations
Thursday 23rd July 2026
Regulatory Implications of AI & Code Generation in Medical Device Software Development
9:30 am
  • Go through what teams must do to verify, validate, and keep traceability when AI tools help write software
  • How to manage tool reliability, version changes, and documentation so AI-generated code remains testable and compliant
  • Practical governance, human oversight, and documentation practices that allow safe use of AI while meeting regulatory expectations
Gerald Rigdon